Phoenix Biotech Acquisition Probability of Future Stock Price Finishing Under 10.61
| PBAXDelisted Stock | USD 10.90 0.00 0.00% |
Phoenix |
Phoenix Biotech Target Price Odds to finish below 10.61
The tendency of Phoenix Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 10.61 or more in 90 days |
| 10.90 | 90 days | 10.61 | near 1 |
Based on a normal probability distribution, the odds of Phoenix Biotech to drop to $ 10.61 or more in 90 days from now is near 1 (This Phoenix Biotech Acquisition probability density function shows the probability of Phoenix Stock to fall within a particular range of prices over 90 days) . Probability of Phoenix Biotech Acqu price to stay between $ 10.61 and its current price of $10.9 at the end of the 90-day period is about 74.7 .
Given the investment horizon of 90 days Phoenix Biotech has a beta of 0.12 indicating as returns on the market go up, Phoenix Biotech average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Phoenix Biotech Acquisition will be expected to be much smaller as well. Additionally Phoenix Biotech Acquisition has an alpha of 0.0154, implying that it can generate a 0.0154 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Phoenix Biotech Price Density |
| Price |
Predictive Modules for Phoenix Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Phoenix Biotech Acqu. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Phoenix Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Phoenix Biotech is not an exception. The market had few large corrections towards the Phoenix Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Phoenix Biotech Acquisition, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Phoenix Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.02 | |
β | Beta against Dow Jones | 0.12 | |
σ | Overall volatility | 0.07 | |
Ir | Information ratio | -0.0077 |
Phoenix Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Phoenix Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Phoenix Biotech Acqu can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Phoenix Biotech Acqu is now traded under the symbol CERO. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Phoenix Biotech Acqu is not yet fully synchronised with the market data | |
| Phoenix Biotech Acqu has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (2.52 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Phoenix Biotech Acquisition currently holds about 553.77 K in cash with (1.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 95.0% of the company outstanding shares are owned by corporate insiders |
Phoenix Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Phoenix Stock often depends not only on the future outlook of the current and potential Phoenix Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Phoenix Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 17.9 M | |
| Cash And Short Term Investments | 475.9 K |
Phoenix Biotech Technical Analysis
Phoenix Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Phoenix Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Phoenix Biotech Acquisition. In general, you should focus on analyzing Phoenix Stock price patterns and their correlations with different microeconomic environments and drivers.
Phoenix Biotech Predictive Forecast Models
Phoenix Biotech's time-series forecasting models is one of many Phoenix Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Phoenix Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Phoenix Biotech Acqu
Checking the ongoing alerts about Phoenix Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Phoenix Biotech Acqu help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Phoenix Biotech Acqu is now traded under the symbol CERO. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Phoenix Biotech Acqu is not yet fully synchronised with the market data | |
| Phoenix Biotech Acqu has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (2.52 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Phoenix Biotech Acquisition currently holds about 553.77 K in cash with (1.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 95.0% of the company outstanding shares are owned by corporate insiders |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Phoenix Stock
If you are still planning to invest in Phoenix Biotech Acqu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Phoenix Biotech's history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |